Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | City View Green Holdings Inc: City View to change business, become investment issuer | 1 | Stockwatch | ||
Do | City View Green Holdings Inc. Announces Proposed Change of Business and Spin-Out of 2590672 Ontario Inc | 140 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 3, 2025) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (the "Company" or "City View"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
27.03. | City View Green Holdings Inc: City View Green extends $1-million financing to May 10 | 1 | Stockwatch | ||
27.03. | City View Green Holdings Inc.: City View Green Holdings Extends Private Placement | 153 | Newsfile | Not for distribution to United States newswire services or for dissemination in the United States.Toronto, Ontario--(Newsfile Corp. - March 27, 2025) - City View Green Holdings Inc. (CSE: CVGR) (OTC... ► Artikel lesen | |
12.02. | City View Green Holdings Inc. Considering Spin Out as Part of Strategic Review | 241 | Newsfile | Toronto, Ontario--(Newsfile Corp. - February 12, 2025) - City View Green Holdings Inc. (CSE: CVGR) (OTCQB: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
CITY VIEW GREEN Aktie jetzt für 0€ handeln | |||||
23.12.24 | City View Green Holdings Inc: City View closes $234,750 first tranche of financing | 3 | Stockwatch | ||
23.12.24 | City View Green Holdings Inc.: City View Green Announces First Tranche Closing and Extension of Its Non-Brokered Private Placement | 325 | Newsfile | Toronto, Ontario--(Newsfile Corp. - December 23, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
27.11.24 | City View Green Holdings Inc: City View Green issues 78.08 million shares for debt | 3 | Stockwatch | ||
27.11.24 | City View Green Holdings Inc. Completes Issuance of Shares in Settlement of Debt | 251 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 27, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
06.11.24 | City View Green Holdings Inc. Announces Completion of Strategic Review and Debt Settlements | 325 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 6, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTCQB: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
18.10.24 | Canadian Cannabis Edibles Producer City View Green To Raise $730K Via Private Placement | 2 | Benzinga.com | ||
17.10.24 | City View Green Holdings Inc: City View Green arranges $1-million private placement | 1 | Stockwatch | ||
17.10.24 | City View Green Holdings Inc.: City View Announces Private Placement of up to $1,000,000 and Enters into IR Agreement | 239 | Newsfile | Toronto, Ontario--(Newsfile Corp. - October 17, 2024) - City View Green Holdings Inc. (CSE: CVGR) (the "Company" or "City View"), an innovative Canadian-based cannabis-infused edibles manufacturing... ► Artikel lesen | |
21.06.24 | City View Green Holdings Inc.: City View Green Announces First Tranche Closing and Extension of its Non-Brokered Private Placement | 612 | Newsfile | Toronto, Ontario--(Newsfile Corp. - June 20, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
06.05.24 | City View Green Holdings Inc.: City View Extends Private Placement of up to $1,000,000 | 568 | Newsfile | Toronto, Ontario--(Newsfile Corp. - May 6, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTC Pink: CVGRF) (the "Company" or "City View"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen | |
17.04.24 | City View Green Holdings Inc. Exits Retail Cannabis Through Ownership in Budd Hutt & Announces Director Resignation | 534 | Newsfile | Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - City View Green Holdings Inc. (CSE: CVGR) (OTCQB: CVGRF) ("City View" or the "Company"), an innovative Canadian-based cannabis-infused edibles... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 20,260 | -4,73 % | Novo Nordisk, BioNxt Solutions, Bayer Aktie: Drei Wege zu Gesundheit und Rendite | Die Pharmabranche boomt - und drei Unternehmen stehen 2025 besonders im Rampenlicht: Novo Nordisk, BioNxt Solutions und Bayer. Alle drei verbindet ein Ziel: Mit innovativen Ansätzen die Gesundheit von... ► Artikel lesen | |
PFIZER | 21,265 | -3,49 % | Investor Woche: Börsencrash durch Trumps Zollhammer, Magnificent 7, Berkshire Hathaway, Anheuser Busch, EON, Allianz, Pfizer | Trumps Zollhammer lässt die Aktienmärkte weltweit abstürzen. Besonders betroffen: Die Magnificent 7. Warren Buffetts hohe Cash-Reserven könnten Berkshire Hathaway zugutekommen. Unternehmen mit geringer... ► Artikel lesen | |
SANOFI | 96,41 | -3,30 % | Sanofis Rilzabrutinib mit FDA-Einstufung für seltene Krankheiten | DJ Sanofis Rilzabrutinib mit FDA-Einstufung für seltene Krankheiten
Von Pierre Bertrand
DOW JONES--Sanofi hat für seinen Medikamentenkandidaten Rilzabrutinib zur Behandlung von zwei seltenen... ► Artikel lesen | |
INNOCAN PHARMA | 0,102 | -9,38 % | Innocan Pharma meldet Ergebnisse für das Gesamtjahr 2024: Verdoppelung des Umsatzes auf 29,4 Millionen US$ | Herzliya, Israel und Calgary, Alberta - 31. März 2025 / IRW-Press / Innocan Pharma Corporation (CSE: INNO) (FWB: IP4) (OTC: INNPF) (das
"Unternehmen" oder "Innocan"), ein pharmazeutisches Technologieunternehmen... ► Artikel lesen | |
DERMAPHARM | 36,200 | -0,82 % | Dermapharm: Dermapharm bleibt für das Geschäftsjahr 2025 vorsichtig optimistisch; mwb research stuft auf HALTEN | Die Dermapharm Holding SE (DMP) hat robuste Finanzergebnisse für das Geschäftsjahr 2024 vorgelegt: Der Umsatz stieg im Jahresvergleich um 4,0% auf 1.181 Mio. EUR, das bereinigte EBITDA legte um 1,7%... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc: Digicann Ventures extends debentures | ||
BAUSCH HEALTH | 4,801 | -6,72 % | Bausch Health Companies Inc.: Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month | Bausch Health's gastroenterology business, Salix Pharmaceuticals, recognizes the complexities of irritable bowel syndrome (IBS) and seeks to make a difference in how the condition is perceived, diagnosed... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,035 | 0,00 % | CSE Bulletin: Consolidation - WPD Pharmaceuticals Inc. (WBIO) | le 23 décembre/December 2024
WPD Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every twenty-five... ► Artikel lesen | |
SINOPHARM | 2,115 | -0,42 % | HTSC Trims SINOPHARM TP to $22.54 as 2024 NP Misses | ||
INDIVA | 0,016 | -100,00 % | SNDL Inc.: SNDL Emerges as Canada's Leading Producer of Edibles with Indiva Acquisition | CALGARY, AB, Nov. 4, 2024 /CNW/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") announced today that, in the context of Indiva Limited's ("Indiva" and together... ► Artikel lesen | |
CSPC PHARMA | 0,604 | -3,45 % | M Stanley Cuts CSPC PHARMA TP to $6.7, Rating Overweight | ||
ORAMED PHARMACEUTICALS | 1,910 | -2,23 % | Oramed Aktie: Besorgniserregende Signale? | Die Oramed Pharmaceuticals Aktie verzeichnete am 22. Februar 2025 einen signifikanten Rückgang. Der Aktienkurs fiel um 3,15 Prozent auf 2,15 USD, was einem Minus von 0,07 USD gegenüber dem vorherigen... ► Artikel lesen | |
ADASTRA | 0,228 | 0,00 % | Adastra Holdings Ltd.: Adastra Holdings Announces New Director | Langley, British Columbia--(Newsfile Corp. - March 3, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2EP) ("Adastra" or the "Company"), a leading cannabis processor and producer of two top Canadian... ► Artikel lesen | |
CATALYST PHARMACEUTICALS | 20,780 | -4,98 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update | Full Year 2024 Total Revenues of $491.7 Million, Marking Another Year of Record Growth Full Year 2024 Total Revenues Grew 23.5% YoY, Driven by Strong Commercial Performance Q4 2024 Net... ► Artikel lesen | |
MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc. Announces Issuance of Third Partial Revocation Order |